Sael Musavyimana

Sael Musavyimana


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Sael MusavyimanaSael Musavyimana
Sael Musavyimana
WDWenle Du
Wenle Du
MLMengyue Li
Mengyue Li
JHJingbo Huang
Jingbo Huang
HKHongtao Kang
Hongtao Kang
QJQian Jiang
Qian Jiang
Canine adenovirus type 2 (CAV-2) is an important respiratory pathogen of dogs and has also emerged as a promising non-human adenoviral vector for gene delivery. However, antibody reagents targeting the CAV-2 penton base remain poorly characterized compared with those directed against the hexon and fiber proteins. In this study, we generated and characterized a mouse monoclonal antibody (mAb), designated 3D5, against the CAV-2 penton base. Recombinant penton base protein expressed in Escherichia coli was used for mouse immunization and hybridoma screening. mAb 3D5 was identified as an IgG2b antibody with a kappa light chain and specifically recognized both recombinant penton base protein and viral antigen in CAV-2-infected MDCK cells by Western blotting and immunofluorescence assays. Sequential truncation mapping localized the antibody-binding region to the N terminus of the penton base, and a recombinant fragment spanning residues 29–36 (RYKGATEG) retained 3D5 reactivity under denaturing conditions. This sequence was identical in 31/33 CAV-2 and 4/4 CAV-1 accession records, and mAb 3D5 reacted with a recombinant CAV-1 preparation. MAb 3D5 showed no neutralizing activity. These results identify a N-terminal linear reactive region recognized by mAb 3D5 and provide a renewable monoclonal antibody reagent for CAV-2 antigen detection and further investigation of penton base antigenicity.